Concepedia

Kevin A. Buczkowski

KA

Statistics

Publications

6

Citations

2.6K

H-Index

6

Active since

2015

Affiliations

Dana-Farber Cancer Institute(Current)

Brigham and Women's Hospital

Harvard University

Broad Institute

Beth Israel Deaconess Medical Center

Kevin A. Buczkowski is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and molecular oncology.

Publications per year

2015–2018

6

Publications

6

Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints

Shohei Koyama, Esra A. Akbay, Yvonne Y. Li et al. · Nature Communications · 2016 · 1.6K citations · Full text

Medicine, Immunology, Oncology +17

STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment

Shohei Koyama, Esra A. Akbay, Yvonne Y. Li et al. · Cancer Research · 2016 · 630 citations · Full text

Medicine, Immunology, Oncology +17

Synergy of radiotherapy and PD-1 blockade in Kras-mutant lung cancer

Grit S. Herter-Sprie, Shohei Koyama, Houari Korideck et al. · JCI Insight · 2016 · 159 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Suppression of Adaptive Responses to Targeted Cancer Therapy by Transcriptional Repression

Maria Rusan, Kapsok Li, Yvonne Li et al. · Cancer Discovery · 2017 · 141 citations · Full text

Medicine, Cancer Biology, Oncology +17

NK Cells Mediate Synergistic Antitumor Effects of Combined Inhibition of HDAC6 and BET in a SCLC Preclinical Model

Yan Liu, Yuyang Li, Shengwu Liu et al. · Cancer Research · 2018 · 52 citations · Full text

Medicine, Oncology, Pharmacology +13

1–5 of 6